Recombinant human thrombomodulin inhibits neutrophil extracellular trap formation in vitro

研究成果: Letter

11 引用 (Scopus)

抜粋

The aim of this study was to investigate the effects of recombinant human-soluble thrombomodulin (rTM) on lipopolysaccharide (LPS)-induced, platelet-dependent neutrophil extracellular trap (NET) formation (NETosis). Human peripheral blood neutrophils and platelets were co-incubated with or without LPS (0.2 μg/ml) in the presence and absence of rTM (2 μg/ml). NETosis was confirmed by immunostaining and confocal microscopy. In the absence of platelets, LPS did not induce NETosis in the neutrophils. NETosis, however, was induced by LPS when neutrophils were co-cultured with platelets (64 % of neutrophils). Notably, rTM was able to fully inhibit NETosis in neutrophils cultured with platelets and in the presence of LPS. rTM did not induce NETosis in this co-culture system (p < 0.01 versus LPS in the absence of rTM). These results show that rTM can suppress LPS-induced platelet-dependent NETosis in vitro.

元の言語English
記事番号48
ジャーナルJournal of Intensive Care
4
発行部数1
DOI
出版物ステータスPublished - 22-07-2016

All Science Journal Classification (ASJC) codes

  • Critical Care and Intensive Care Medicine

フィンガープリント Recombinant human thrombomodulin inhibits neutrophil extracellular trap formation in vitro' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用